Literature DB >> 18295762

The efficacy of the transfer of twice frozen-thawed embryos with the vitrification method.

Yoko Kumasako1, Eiko Otsu, Takafumi Utsunomiya, Yasuhisa Araki.   

Abstract

OBJECTIVE: To confirm the clinical benefits of recryopreserved, twice-thawed embryo transfer (ET).
DESIGN: Retrospective study.
SETTING: Private fertility clinic. PATIENT(S): Forty-nine women whose embryos had been refrozen after a previous frozen-thawed ET. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Comparison of implantation and pregnancy rates of twice-cryopreserved, twice-thawed embryos versus once-cryopreserved, once-thawed embryos. RESULT(S): The pregnancy rate per ET cycle was 27.8% in the refrozen group and 25.9% in the control group (no statistically significant difference). The implantation rate was 25.0% in the refrozen group and 19.3% in the control group (no statistically significant difference). CONCLUSION(S): The refreezing of supernumerary embryos can prevent ovarian hyperstimulation syndrome in stimulated patients and in those who have experienced repeated failed pregnancies. If unexpected supernumerary embryos are available for recryopreservation after frozen-thawed ET, these embryos may be revitrified for a future transfer.

Entities:  

Mesh:

Year:  2008        PMID: 18295762     DOI: 10.1016/j.fertnstert.2007.11.079

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Vitrification of human blastocysts previously cryopreserved by slow controlled-rate freezing at the cleavage stage.

Authors:  S Lierman; E Van den Abbeel; P De Sutter
Journal:  J Assist Reprod Genet       Date:  2014-01-04       Impact factor: 3.412

2.  Cumulative live birth rate after two single frozen embryo transfers (eSFET) versus a double frozen embryo transfer (DFET) with cleavage stage embryos: a retrospective cohort study.

Authors:  Ma Luisa López Regalado; Ana Clavero; M Carmen Gonzalvo; María Serrano; Luis Martínez; Juan Mozas; Fernando Rodríguez-Serrano; Juan Fontes; Bárbara Romero; Jose A Castilla
Journal:  J Assist Reprod Genet       Date:  2014-09-30       Impact factor: 3.412

3.  Live birth rate following a euploid blastocyst transfer is not affected by double vitrification and warming at cleavage or blastocyst stage.

Authors:  Efstathios Theodorou; Benjamin P Jones; Daniella F Cardenas Armas; Carleen Heath; Paul Serhal; Jara Ben-Nagi
Journal:  J Assist Reprod Genet       Date:  2022-02-26       Impact factor: 3.357

4.  Alterations of miR-16, miR-let-7a and their target genes expression in human blastocysts following vitrification and re-vitrification.

Authors:  Maryam Daneshvar; Mansoureh Movahedin; Mohammad Salehi; Mehrdad Noruzinia
Journal:  Reprod Biol Endocrinol       Date:  2021-10-09       Impact factor: 5.211

5.  "Double Frozen Transfer" Could Influence the Perinatal and Children's Growth: A Nested Case-Control Study of 6705 Live Birth Cycles.

Authors:  Jie Gao; Yiyuan Zhang; Linlin Cui; Tao Zhang; Bingjie Wu; Shanshan Gao; Zi-Jiang Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-12       Impact factor: 6.055

6.  National Survey Highlights the Urgent Need for Standardisation of Embryo Transfer Techniques in the UK.

Authors:  Lewis Nancarrow; Nicola Tempest; Andrew J Drakeley; Roy Homburg; Richard Russell; Dharani K Hapangama
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

7.  Live birth in a woman with recurrent implantation failure and adenomyosis following transfer of refrozen-warmed embryos.

Authors:  Somayyeh Safari; Azita Faramarzi; Azam Agha-Rahimi; Mohammad Ali Khalili
Journal:  Clin Exp Reprod Med       Date:  2016-09-22

8.  Thaw, biopsy and refreeze strategy for PGT-A on previously cryopreserved embryos.

Authors:  M Wilding; M Terribile; I Parisi; G Nargund
Journal:  Facts Views Vis Obgyn       Date:  2019-09

9.  Effect of the Re-Vitrification of Embryos at Different Stages on Embryonic Developmental Potential.

Authors:  Jingyu Li; Shun Xiong; Yanhua Zhao; Chong Li; Wei Han; Guoning Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-14       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.